LeVasseur Capital Partners’s Bausch Health BHC Stock Holding History

LeVasseur Capital Partners’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-128,269	Closed	-$3.37M	–	7
2016 Q1	$3.37M	Sell	128,269 -128,269	-50%	-$9.49M	6.97%	5
2015 Q4	$26.1M	Buy	256,538 +94,144	+58%	+$10.6M	31.38%	1
2015 Q3	$29M	Sell	162,394 -26,410	-14%	-$6.16M	29.76%	1
2015 Q2	$41.9M	Sell	188,804 -10,200	-5%	-$2.26M	34.97%	1
2015 Q1	$39.5M	Hold	199,004	–	–	40.1%	1
2014 Q4	$28.5M	Buy	199,004 +8,600	+5%	+$1.16M	33.38%	1
2014 Q3	$25M	Hold	190,404	–	–	29.94%	1
2014 Q2	$24M	Hold	190,404	–	–	29.5%	1
2014 Q1	$25.1M	Hold	190,404	–	–	29.51%	1
2013 Q4	$22.4M	Buy	+190,404	New	+$20.9M	28.05%	1

Other funds holding BHC

PSCM

Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LeVasseur Capital Partners's BHC Position: Q2 2016 in Review

LeVasseur Capital Partners sold out of Bausch Health (BHC) in Q2 2016, closing a stake of 128,269 shares — an estimated $3.37M sold.

LeVasseur Capital Partners first reported a position in BHC in Q4 2013 and held it in 10 quarters. The position peaked at $41.9M in Q2 2015. 347 funds tracked by Wall St. Rank hold BHC as of Q2 2016.

LeVasseur Capital Partners reported no remaining Bausch Health position as of Q2 2016 after selling out during the quarter.
LeVasseur Capital Partners sold 128,269 Bausch Health shares in Q2 2016, an estimated $3.37M.
LeVasseur Capital Partners first reported a position in Bausch Health in Q4 2013 and held it in 10 quarters.
LeVasseur Capital Partners's Bausch Health position peaked at $41.9M in Q2 2015.
347 funds tracked by Wall St. Rank held Bausch Health as of Q2 2016.

Based on LeVasseur Capital Partners's 13F filing for Q2 2016, filed 15 Aug 2016.